Nisha Acharya

MD MS

Director, Ocular Inflammatory Disease and Uveitis Clinic
Ophthalmologist
Classical music enthusiast and amateur violinist

About me

Dr. Nisha Acharya is an ophthalmologist who specializes in diagnosing and managing patients with infectious and inflammatory eye diseases. Her expertise includes the latest treatments for uveitis, a group of conditions that cause sight-threatening inflammation in the eye.

Acharya cares for both adults and children at the UCSF Francis I. Proctor Foundation for Research in Ophthalmology, where she directs the Ocular Inflammatory Disease and Uveitis Clinic. To bring her patients the best possible care, she takes a collaborative approach, working with rheumatologists, internists, dermatologists, pulmonologists and pediatricians, as needed.

Acharya's research focuses on designing and implementing epidemiological studies to determine the risk factors that affect outcomes for patients with uveitis and other inflammatory eye diseases. She also designs and implements clinical trials for these conditions. Her current projects include epidemiological studies on immunosuppressive therapies, juvenile idiopathic arthritis-associated uveitis, and the impact of the shingles vaccine on the eye.

Acharya completed a bachelor's degree in biological sciences and a master's degree in health services research at Stanford University before earning her medical degree from UCSF. She completed a residency in ophthalmology at Massachusetts Eye and Ear Infirmary, which is part of Harvard Medical School. She completed fellowships in cornea and external disease and uveitis at UCSF's Francis I. Proctor Foundation as well as a research fellowship at Genentech.

Acharya serves on the American Uveitis Society's executive committee. She belongs to the American Academy of Ophthalmology and Association for Research in Vision and Ophthalmology.

  • Education

    UCSF, MD, 2000

    Stanford University, BS, Biological Sciences, 1996

    Stanford University, MS, Health Services Research, 1996

  • Residencies

    Massachusetts Eye and Ear Infirmary/Harvard Medical School, Ophthalmology, 2004

  • Fellowships

    UCSF, Cornea and Uveitis, 2005

    Genentech, Clinical Research, 2006

  • Board Certifications

    Ophthalmology, American Board of Ophthalmology

  • Academic Title

    Professor

My hope is to help patients with inflammatory eye diseases reach their full potential in life and to determine how to optimally treat them through research.
Decorative Caduceus

Adalimumab vs. Conventional Immunosuppression for Uveitis Trial

Non-infectious intermediate, posterior, and panuveitides are chronic, potentially-blinding diseases. Vision-threatening cases require long-term therapy with oral corticosteroids and immunosuppression. Based upon prel...

Recruiting

Decorative Caduceus

Macular Edema Ranibizumab v. Intravitreal Anti-inflammatory Therapy Trial

The Macular Edema Ranibizumab v. Intravitreal anti-inflammatory Therapy (MERIT) Trial will compare the relative efficacy and safety of intravitreal methotrexate, intravitreal ranibizumab, and the intravitreal dexamet...

Recruiting

Share